Class Action Suit Claims Celgene Gamed the System to Guard Thalomid, Revlimid Monopolies

Drug Industry Daily
A A
A health plan for a carpenters’ union filed a class action lawsuit against Celgene, claiming the drugmaker engaged in anti-competitive practices to maintain its monopoly on Thalomid and Revlimid.

To View This Article:

Login

Subscribe To Drug Industry Daily